Clinical outcomes after conversion from brand-name tacrolimus (Prograf) to a generic formulation in renal transplant recipients: A retrospective cohort study

Kwaku Marfo, Samuel Aitken, Enver Akalin

Research output: Contribution to journal › Article › peer-review

13 Scopus citations

Fingerprint

Dive into the research topics of 'Clinical outcomes after conversion from brand-name tacrolimus (Prograf) to a generic formulation in renal transplant recipients: A retrospective cohort study'. Together they form a unique fingerprint.